Načítá se...
Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
BACKGROUND: Recent reports showed neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), as a predictor of progression-free survival (PFS) and overall survival (OS) in various malignancies. MATERIALS AND METHODS: We retrospectively examined...
Uloženo v:
Vydáno v: | J Lab Physicians |
---|---|
Hlavní autoři: | , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Medknow Publications & Media Pvt Ltd
2018
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6210833/ https://ncbi.nlm.nih.gov/pubmed/30498304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/JLP.JLP_36_18 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|